The 4th Worldwide Network for Blood and Marrow Transplantation (WBMT) Workshop and Symposium
| 15-17 Jan 2017 |
Riyadh, Saudi Arabia

WBMT Workshop in Riyadh 2017

Chairs: Yoshihisa Kodera (Japan), Dietger Niederwieser (Germany),Hassan Elsolh (KSA),
             Daniel Weisdorf (USA) and Hildegard Greinix (Austria)

08:30-09:00    Inagural Program  
  Welcome by: Qassim AlQasabi (KFSH&RC)
  Welcome by: Dietger Niederwieser (WBMT)
  Welcome by: Hassan Elsolh (EMBMT)
09:00-09:30 WHO and HCT José Nunez (Switzerland)
09:30-09:45 Global perspective of HCT Dietger Niederwieser (Germany)
09:45-10:00 Coffee Break  


Chairs: Daniel Weisdorf (USA) and Yoshihisa Kodera (Japan)

10:00-10:10 Explanation of Program Agenda Hildegard Greinix (Austria)
10:10-12:40 Country Presentations
10:10-10:20 Mohamed-Amine Bekadja (Algeria)
10:20-10:30 Alaa Elhaddad (Egypt)
10:30-10:40 Ardeshir Ghavamzadeh (Iran)
10:40-10:50 Mahmoud Sarhan (Jordan)
10:50-11:00 Salem Al-Shammari (Kuwait)
11:00-11:10 Ali Bazarbachi (Lebanon)
11:10-11:20 Asma El Quessar (Morocco)
11:20-11:30 Parvez Ahmed (Pakistan)
11:30-11:40 Salman Adil (Pakistan)
11:40-11:50 Mohamed Bakr (Qatar)
11:50-12:00 Marwan Shaheen (KSA)
12:00-12:10 Nicolas Novitzky (South Africa and AFBMT)
12:10-12:20 Tarek Ben Othman (Tunisia)
12:20-12:30 Mutlu Arat (Turkey)
12:30-12:40 Asma Alolama (UAE)
12:40-14:00 Lunch


Chairs: Mary Horowitz (USA) and Mohamad Mohty (France)

14:00-14:15 What do we need to get started? Hildegard Greinix (Austria)
14:15-14:30 Strategic Priorities for HCT Programs in the EMRO Region Syed Osman Ahmed (KSA)
14:30-15:10 Roundtable Discussion: Minimum requirements of an effective HCT program Moderator:
Daniel Weisdorf (USA)
Syed Osman Ahmed (KSA)
Andrea Bacigalupo (Italy)
Hildegard Greinix (Austria)
Mary Horowitz (USA)
Peggy Lu (China)
Hossam Kamel Mahmoud (Egypt)
Mohamad Mohty (France)
Moosa Patel (South Africa)
15:10-15:30 Coffee Break  


Chairs: Marcelo Pasquini (USA) and Ibraheem Motabi (KSA)

15:30-15:45 Autologous vs. allogeneic HCT to get started Naeem Chaudhri (KSA)
15:45-16:00 Can We Lower the Cost and Maintain Quality Nicolas Novitzky (South Africa)
16:00-16:40 Roundtable Discussion: Getting started and containing cost Moderator:
Marcelo Pasquini (USA)
Salman Adil (Pakistan)
Ahmad Alsaeed (KSA)
Nosa Bazuaye (Nigeria)
Naeem Chaudhri (KSA)
Ibraheem Motabi (KSA)
Nicolas Novitzky (South Africa))
Doug Rizzo (USA)
Bipin Savani (USA)


Chairs: Robert Peter Gale (UK) and Parameswaran Hari (USA)

16:40-16:55 Current indications for HCT in adults Shinichiro Okamoto (Japan)
16:55-17:10 Current indications for HCT in pediatrics Adriana Seber (Brazil)
17:10-17:50 Roundtable Discussion: Limitations and contraindications of HCT Moderator:
Wael Saber (USA)
Hazzaa Alzahrani (KSA)
Mohamed Bayoumy (KSA)
Riad El Fakih (KSA)
Robert Peter Gale (UK)
Parameswaran Hari (USA)
Adetola Kassim (USA)
Shinichiro Okamoto (Japan)
Adriana Seber (Brazil)


Chairs:Jörg Halter (Switzerland) and Ibrahim Yakoub Agha (France)

08:30-08:45 Pros and cons of different stem cell sources and their availability in EMRO Region Feras Alfraih (KSA)
08:45-09:00 HLA typing, donor selection and donor registries Dennis Confer (USA)
09:00-09:15 Donor safety including minors as donors Jörg Halter (Switzerland)
09:15-10:00 Roundtable Discussion: Donor selection and donor safety Moderator:
Jörg Halter (Switzerland)
Ibrahim Yakoub Agha (France)
Ali Alahmari (KSA)
Feras Alfraih (KSA)
Dennis Confer (USA)
David Dennison (Oman)
Yoshihisa Kodera (Japan)
Saloua Ladeb (Tunisia)
Navneet Majhail (USA)
10:00-10:15 Coffee Break  


Chairs: Jane Apperley (UK) and Nelson Chao (USA)

10:15-10:30 How to become a transplant physician, staff nurse and technician Jane Apperley (UK)
10:30-10:45 Ways to gain experience, training abroad, twinning with other institutes,internet, telemedicine and others Mohamed Kharfan Dabaja (USA)
10:45-11:30 Roundtable Discussion: Establish a curriculum for training in HCT and tools for education Moderator:
Jane Apperley (UK)
Hani Alhashmi (KSA)
Basim Albeirouti (KSA)
Nelson Chao (USA)
Mohamed Kharfan Dabaja (USA)
Mehdi Hamadani (USA)
Ahmad Ibrahim (Lebanon)
Naynesh Kamani (USA)
Abu Jafar Saleh (Bangladesh)


Chairs: Reguia Belkhedim and EMBMT Nurse Members (KSA)

11:30-11:45 A. Reguia Belkhedim (KSA)
11:45-12:00 B. Joyce Neumann (USA)
12:00-12:15 C. Julie Stensness (KSA)
12:15-12:30 Discussion
12:30-13:45 Lunch


Chairs: Mickey Koh (Singapore/UK) and Hind Alhumaidan (KSA)

13:45-14:00 Minimal requirements for a cell processing lab Mickey Koh (Singapore/UK)
14:00-14:15 Minimal requirements for an HLA laboratory Abulghani Tbakhi (Jordan)
14:15-14:30 Stem cell processing: Method and graft characterization Paul Eldridge (USA)
14:30-15:10 Roundtable Discussion: How to successfully establish a cell processing facility Moderator:
Mickey Koh (Singapore/UK)
Miguel Abboud (Lebanon)
Moheeb Alawwami (KSA)
Hind Alhumaidan (KSA)
Paul Eldridge (USA)
Usama Gergis (USA)
Abulghani Tbakhi (Jordan)TBC
15:10-15:30 Coffee Break  


Chairs: Kathy Loper (USA) and Walid Rasheed (KSA)

15:30-15:45 Overview and principles of a quality system Kathy Loper (USA)
15:45-16:00 Overview of standards and accreditation in HCT Eoin McGrath (Spain)
16:00-16:15 Practical implementation – Essential elements resource tool Nina Worel (Austria)
16:15-16:30 Where do we first start? From following standards to successfully obtaining accreditation Amal Alseraihy (KSA)


Chairs: Doug Rizzo (USA) and Rafael Duarte (Spain)

16:30-16:45 The importance of outcome databases Mary Horowitz (USA)
16:45-17:00 Minimum requirements for establishment of an outcome registry Fazal Hussain (KSA)
17:00-17:15 The WBMT global survey Helen Baldomero (Switzerland)
17:15-17:30 EMBMT registry, moving forward with extended reporting to EMBMT Moderator:
Mary Horowitz (USA)
Helen Baldomero (Switzerland)
Rafael Duarte (Spain)
Shahrukh Hashmi (KSA)
Fazal Hussain (KSA)
Mohamad Mohty (France)
Marcelo Pasquini (USA)
Doug Rizzo (USA)
Wael Saber (USA)
17:30-17:45 Concluding Remarks Dennis Confer (USA)